Attached files

file filename
10-Q - QUARTERLY REPORT - Icagen, Inc.f10q0617_icageninc.htm
EX-32.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1 - Icagen, Inc.f10q0617ex32i_icageninc.htm
EX-31.2 - CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER, PURSUANT TO SECTION 302 OF THE - Icagen, Inc.f10q0617ex31ii_icageninc.htm
EX-31.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER, PURSUANT TO SECTION 302 OF THE - Icagen, Inc.f10q0617ex31i_icageninc.htm
EX-10.12 - SECOND AMENDMENT TO ASSET PURCHASE AND COLLABORATION AGREEMENT BY AND BETWEEN PF - Icagen, Inc.f10q0617ex10xii_icageninc.htm

 Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Icagen, Inc. (the “Registrant”) on Form 10-Q for the period ending June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Korb, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: August 16, 2017 By: /s/ Mark Korb
    Chief Financial Officer
    (Principal Financial Officer)